Kalvista Pharmaceuticals Inc (KALV)

07:01 AM

KalVista Pharmaceuticals to Host Third Quarter Financial Results Conference Call and Webcast on November 11, 2025 - The Joplin Globe

07:01 AM

03:16 AM

Multi asset correlation models including KalVista Pharmaceuticals Inc.Weekly Profit Recap & Daily Oversold Stock Bounce Ideas - newser.com

03:16 AM

01:51 AM

How KalVista Pharmaceuticals Inc. stock performs in high volatility marketsJuly 2025 Analyst Calls & Weekly Chart Analysis and Trade Guides - newser.com

01:51 AM

12:58 PM

Using R and stats models for KalVista Pharmaceuticals Inc. forecastingJuly 2025 Pullbacks & Weekly Market Pulse Updates - newser.com

12:58 PM

12:39 PM

Can KalVista Pharmaceuticals Inc. (4XC1) stock sustain margin levelsQuarterly Earnings Summary & Reliable Price Breakout Signals - newser.com

12:39 PM

12:03 PM

Will KalVista Pharmaceuticals Inc. stock reach Wall Street targetsCPI Data & Weekly Breakout Watchlists - newser.com

12:03 PM

Nov 02, 2025

How strong is KalVista Pharmaceuticals Inc. (4XC1) stock earnings growthJuly 2025 PostEarnings & Step-by-Step Swing Trade Plans - newser.com

Nov 02, 2025

Nov 02, 2025

Will KalVista Pharmaceuticals Inc. stock attract more institutional investorsMarket Trend Summary & Daily Stock Trend Reports - newser.com

Nov 02, 2025

Nov 02, 2025

What makes KalVista Pharmaceuticals Inc. stock attractive to growth funds2025 Price Momentum & Smart Money Movement Tracker - newser.com

Nov 02, 2025

Nov 02, 2025

Exit strategy if you’re trapped in KalVista Pharmaceuticals Inc.July 2025 Big Picture & Safe Entry Momentum Tips - newser.com

Nov 02, 2025

Nov 01, 2025

Will a bounce in KalVista Pharmaceuticals Inc. offer an exit2025 Support & Resistance & Daily Oversold Bounce Ideas - newser.com

Nov 01, 2025

Nov 01, 2025

How hedge fund analytics apply to KalVista Pharmaceuticals Inc. stockM&A Rumor & AI Driven Price Forecasts - newser.com

Nov 01, 2025

Nov 01, 2025

Is KalVista Pharmaceuticals Inc. (4XC1) stock a defensive play amid uncertaintyJuly 2025 Review & Technical Buy Zone Confirmation - newser.com

Nov 01, 2025

Nov 01, 2025

Will KalVista Pharmaceuticals Inc. (4XC1) stock keep high P E multiplesJuly 2025 Catalysts & Safe Entry Momentum Stock Tips - newser.com

Nov 01, 2025

Nov 01, 2025

Will KalVista Pharmaceuticals Inc. (4XC1) stock benefit from commodity supercycleJuly 2025 Market Mood & Verified Technical Trade Signals - newser.com

Nov 01, 2025

Oct 31, 2025

KalVista, Ionis/Sobi among latest to win EU nod for rare disease drugs - MSN

Oct 31, 2025

Oct 31, 2025

How to track smart money flows in KalVista Pharmaceuticals Inc.Weekly Trend Report & Weekly Top Gainers Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Emerald Mutual Fund Advisers Trust Increases Stake in KalVista Pharmaceuticals, Inc. $KALV - MarketBeat

Oct 31, 2025

Oct 31, 2025

Why KalVista Pharmaceuticals Inc. (4XC1) stock is favored by hedge fundsJuly 2025 EndofMonth & Accurate Entry and Exit Point Alerts - newser.com

Oct 31, 2025

Oct 30, 2025

What market sentiment indicators show for KalVista Pharmaceuticals Inc. (4XC1) stock2025 Institutional Moves & Consistent Growth Stock Picks - newser.com

Oct 30, 2025

Oct 30, 2025

Emerald Advisers LLC Boosts Stock Position in KalVista Pharmaceuticals, Inc. $KALV - MarketBeat

Oct 30, 2025

Oct 30, 2025

KalVista Pharmaceuticals (NASDAQ:KALV) Shares Pass Below Fifty Day Moving AverageWhat's Next? - MarketBeat

Oct 30, 2025

Oct 30, 2025

KalVista Pharmaceuticals to Present New EKTERLY® (sebetralstat) Data at the American College of Allergy, Asthma & Immunology 2025 Annual Scientific Meeting - The Joplin Globe

Oct 30, 2025

Oct 29, 2025

KalVista’s Icatibant Study: A Potential Game-Changer for HAE Treatment? - MSN

Oct 29, 2025